ClearPoint Neuro (CLPT) Capital Expenditures (2011 - 2026)

ClearPoint Neuro has disclosed Capital Expenditures across 14 years of filings, most recently posting $645000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $645000.0, up 252.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $984000.0 (up 114.85% YoY), and the FY2025 annual result was $522000.0, up 89.82% from the prior year.
• Capital Expenditures came in at $645000.0 for Q1 2026 at ClearPoint Neuro, up from $49000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $645000.0 in Q1 2026 to a low of $12000.0 in Q3 2024.
• The 5-year median for Capital Expenditures is $91000.0 (2025), against an average of $160800.0.
• Across the five-year window, Capital Expenditures slumped 94.89% in 2024 and jumped 1558.33% in 2025, its largest moves.
• ClearPoint Neuro's Capital Expenditures stood at $39000.0 in 2022, then plunged by 46.15% to $21000.0 in 2023, then surged by 1152.38% to $263000.0 in 2024, then slumped by 81.37% to $49000.0 in 2025, then jumped by 1216.33% to $645000.0 in 2026.
• The last three Capital Expenditures figures came in at $645000.0 (Q1 2026), $49000.0 (Q4 2025), and $199000.0 (Q3 2025), per Business Quant data.